↓ Skip to main content

Dove Medical Press

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
65 Mendeley
Title
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
Published in
Neuropsychiatric Disease and Treatment, June 2013
DOI 10.2147/ndt.s45840
Pubmed ID
Authors

Seyed-Mohammad Fereshtehnejad, Dorota Religa, Eric Westman, Dag Aarsland, Johan Lökk, Maria Eriksdotter

Abstract

Whether dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) should be considered as one entity or two distinct conditions is a matter of controversy. The aim of this study was to compare the characteristics of DLB and PDD patients using data from the Swedish Dementia Quality Registry (SveDem).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Netherlands 1 2%
Unknown 63 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Student > Ph. D. Student 9 14%
Student > Master 8 12%
Other 8 12%
Student > Bachelor 6 9%
Other 8 12%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 18 28%
Psychology 7 11%
Nursing and Health Professions 5 8%
Agricultural and Biological Sciences 3 5%
Social Sciences 3 5%
Other 9 14%
Unknown 20 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2013.
All research outputs
#22,759,452
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,584
of 3,132 outputs
Outputs of similar age
#181,525
of 206,481 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#45
of 54 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,481 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.